An Observational Study of BOTOX for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Trial Profile

An Observational Study of BOTOX for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Overactive bladder; Urinary incontinence
  • Focus Therapeutic Use
  • Acronyms GRACE
  • Sponsors Allergan
  • Most Recent Events

    • 08 Mar 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 10 Sep 2015 Planned End Date changed from 1 Feb 2017 to 1 Dec 2016 as per ClinicalTrials.gov record.
    • 10 Sep 2015 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top